Vyvanse vs. Dexampex: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Vyvanse and Dexampex. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 44,784 people who take Vyvanse and Dexampex, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Dexampex?
Dexampex has active ingredients of dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 60 Dexampex users. Check the latest studies of Dexampex.
44,784 people who take Vyvanse and Dexampex are studied.
Drugs being compared in this study:
- Dexampex (dextroamphetamine sulfate)
- Vyvanse (lisdexamfetamine dimesylate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Vyvanse:
- not at all: 1.9500000000000002 %
- somewhat: 11.63 %
- moderate: 32.97 %
- high: 38.89 %
- very high: 14.57 %
Dexampex:
- not at all: 1.51 %
- somewhat: 12.44 %
- moderate: 32.44 %
- high: 37.21 %
- very high: 16.4 %
Want to compare Vyvanse with Dexampex?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dexampex:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on lisdexamfetamine dimesylate and dextroamphetamine sulfate (the active ingredients of Vyvanse and Dexampex, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Diastat and Felbatol - 3 seconds ago
- Drug interactions of Gentamicin and Emtricitabine - 5 seconds ago
- Drug interactions of Qvar and Levetiracetam - 7 seconds ago
- Drug interactions of Dolobid and Enbrel - 8 seconds ago
- Drug interactions of Acthar and Synthroid - 9 seconds ago
- Could Zithromax cause Infectious Mononucleosis? - 13 seconds ago
- Drug interactions of Glucophage Xr and Euthyrox - 14 seconds ago
- Could Klor-Con cause Dysuria Aggravated? - 17 seconds ago
- Could Klor-Con cause Sedation? - 17 seconds ago
- Could Amoxicillin And Clavulanate Potassium cause Humerus Fracture? - 17 seconds ago